Pharmaceutical Chartbook

In this new edition of Pharmaceutical Chartbook, readers get a bird?s-eye view of the major trends in the pharmaceutical industry. Major challenges are facing the pharmaceutical industry, challenges which may have an impact on the rate of discovery of new pharmaceuticals, innovation in prescribing, causes of major shifts in distribution channels, and ways in which pharmaceuticals are reimbursed. As the pharmaceutical field is becoming more complex, the necessity arises to illustrate, document, and provide an overview of the major trends impinging on drug sales in a clear and accessible manner. In graphical form, Pharmaceutical Chartbook provides facts and figures for executives and managers in the industry. They, along with others involved in the pharmaceutical industry, will find this updated edition to be:comprehensive: Pharmaceutical Chartbook provides in 10 topic areas, an overview of issues involved in the discovery, distribution, and purchase of drugs.selective: Only major issues directly relevant to changes in the field are included in this edition.descriptive of trends: The charts and graphs allow for interpretive powers beyond the usual cross-sectional or snapshot approach for data presentation. contemporary in nature: The graphs are the most up-to-date and include information that is not yet publicly available.easy to use: In addition to providing a quick review of the major trends in the industry, the tables and graphs in Pharmaceutical Chartbook can be used as illustrations or included in presentations, speeches, seminars, etc. Currently, the pharmaceutical industry is gearing up for increased competition induced by managed care. Strategies to meet the challenge of increased competition include forming alliances with the generic pharmaceutical industry and integrating operations via horizontal and vertical merges. The facts and trends in the Pharmaceutical Chartbook provide needed data for executives and managers in the industry; administrators in government agencies such as the GAO, OBM, FDA, and Medicaid; administrators in public, semi-private, and private institutions like OTA, HIH, AHCPR; academicians and faculty in medical, pharmacy, public health, and nursing; and contract research organizations and other consulting firms.